Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 28, 2013; 19(40): 6814-6824
Published online Oct 28, 2013. doi: 10.3748/wjg.v19.i40.6814
Published online Oct 28, 2013. doi: 10.3748/wjg.v19.i40.6814
Figure 2 Curcumin shows enhanced cytotoxicity toward PTEN-deficient cells.
A-E: Cytotoxic effects of irinotecan (CPT-11), 5-fluorouracil (5-FU), dihydroartemisinin (DHA), oxaliplatin (OXA) and curcumin (Cur) on cell viability of HCT116 phosphatase and tensin homolog deleted on chromosome 10 (PTEN)+/+ and PTEN-/- cells were determined using the MTT assay; F: Cytotoxic effects of curcumin (Cur) on HCT116 p53+/+ and p53-/- cells ( bP < 0.01 vs control group).
- Citation: Chen L, Li WF, Wang HX, Zhao HN, Tang JJ, Wu CJ, Lu LT, Liao WQ, Lu XC. Curcumin cytotoxicity is enhanced by PTEN disruption in colorectal cancer cells. World J Gastroenterol 2013; 19(40): 6814-6824
- URL: https://www.wjgnet.com/1007-9327/full/v19/i40/6814.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i40.6814